Treatment of hemophilia A with human antihemophilic globulin.

[1]  C. Steer.  PANIC AND PHOBIA , 1959 .

[2]  M. Blombäck,et al.  On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time. , 2009, Acta medica Scandinavica.

[3]  I. Nilsson,et al.  Von Willebrand's disease and its correction with human plasma fraction 1-0. , 2009, Acta medica Scandinavica.

[4]  A. A. Sharp,et al.  The toxicity and fate of injected animal antihaemophilic globulin. , 1957, Lancet.

[5]  R. Biggs.  Assay of antihaemophilic globulin in treatment of haemophilic patients. , 1957, Lancet.

[6]  R. G. Macfarlane,et al.  Surgery in haemophilia; the use of animal antihaemophilic globulin and human plasma in thirteen cases. , 1957, Lancet.

[7]  G. Vaughan.  Children in hospital. , 1957, Lancet.

[8]  M. Nyman,et al.  Studies on the serum haptoglobin level in hemoglobinemia and its influence on renal excretion of hemoglobin. , 1957, Blood.

[9]  P. Wolf,et al.  A concentrate of human antihaemophilic factor; its use in six cases of haemophilia. , 1957, Lancet.

[10]  I. Nilsson,et al.  [Female hemophilia and its management with human antihemophilic globulin]. , 1956, Nordisk medicin.

[11]  P. Wolf.  Assay of Antihaemophilic Factor using the Prothrombin Conversion Ratio , 1956, British journal of haematology.

[12]  J. Lewis,et al.  Hemorrhagic disease with circulating inhibitors of blood clotting: anti-AHF and anti-PTC in eight cases. , 1956, Blood.

[13]  W. Pitney.  The Assay of Antihaemophilic Globulin (AHG) in Plasma , 1956, British journal of haematology.

[14]  G. Fraenkel,et al.  Gunshot wounds in a haemophilic patient; successful treatment by animal antihaemophilic globulin and surgery. , 1955, Lancet.

[15]  E. Bidwell.  The Purification of Antihaemophilic Globulin from Animal Plasma , 1955, British journal of haematology.

[16]  K. Brinkhous,et al.  Antihemophilic Factor (AHF) Levels Following Transfusions of Blood, Plasma and Plasma Fractions.∗ , 1955, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[17]  R. Biggs,et al.  The Assay of Antihaemophilic‐Globulin Activity , 1955, British journal of haematology.

[18]  E. Bidwell.  The Purification of Bovine Antihaemophilic Globulin , 1955, British journal of haematology.

[19]  A. Winterstein.  Zur Biochemie der Gerinnungsfaktoren , 1955 .

[20]  F. Koller.  Klinik und Therapie der plasmatisch bedingten hiimorrhagischen Diathesen , 1955 .

[21]  R. Biggs,et al.  Bovine antihaemophilic globulin in the treatment of haemophilia. , 1954, Lancet.

[22]  K. Brinkhous,et al.  Newer approaches to the study of hemophilia and hemophilioid states. , 1954, Journal of the American Medical Association.

[23]  A. S. Douglas,et al.  The Thromboplastin Generation Test , 1953, Journal of clinical pathology.

[24]  K. Brinkhous,et al.  MILD HEMOPHILIA: AN ALLELIC FORM OF THE DISEASE° , 1953, The American journal of the medical sciences.

[25]  C. S. Davidson,et al.  CHEMICAL, CLINICAL AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION: XXXII. THE COAGULATION DEFECT IN HEMOPHILIA. AN IN VITRO AND IN VIVO COMPARISON OF NORMAL AND HEMOPHILIC WHOLE BLOOD, PLASMA AND DERIVED PLASMA PROTEIN FRACTIONS. , 1946, The Journal of clinical investigation.

[26]  S. Creveld,et al.  Use of Normal Human Plasma Fractions in Hæmophilia , 1946, Nature.

[27]  R. A. Kekwick,et al.  Fractionation of Human Plasma with Ether , 1946, Nature.

[28]  Strong Le,et al.  Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. , 1946 .

[29]  C. S. Davidson,et al.  THE COAGULATION DEFECT IN HEMOPHILIA: THE EFFECT, IN HEMOPHILIA, OF THE PARENTERAL ADMINISTRATION OF A FRACTION OF THE PLASMA GLOBULINS RICH IN FIBRINOGEN. , 1945, The Journal of clinical investigation.

[30]  C. S. Davidson,et al.  STUDIES IN BLOOD COAGULATION: THE COAGULATION PROPERTIES OF CERTAIN GLOBULIN FRACTIONS OF NORMAL HUMAN PLASMA IN VITRO. , 1945, The Journal of clinical investigation.

[31]  R. M. Ferry,et al.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XV. THE PROTEINS CONCERNED IN THE BLOOD COAGULATION MECHANISM. , 1944, The Journal of clinical investigation.

[32]  E. Lozner,et al.  THE COAGULATION DEFECT IN HEMOPHILIA: STUDIES OF THE CLOT PROMOTING ACTIVITY ASSOCIATED WITH PLASMA EUGLOBULIN IN HEMOPHILIA. , 1939, The Journal of clinical investigation.

[33]  E. Lozner,et al.  THE COAGULATION DEFECT IN HEMOPHILIA: THE CLOT PROMOTING ACTIVITY IN HEMOPHILIA OF BERKEFELDED NORMAL HUMAN PLASMA FREE FROM FIBRINOGEN AND PROTHROMBIN. , 1939, The Journal of clinical investigation.

[34]  F. H. Taylor,et al.  THE COAGULATION DEFECT IN HEMOPHILIA. STUDIES ON THE REFRACTORY PHASE FOLLOWING REPEATED INJECTIONS OF GLOBULIN SUBSTANCE DERIVED FROM NORMAL HUMAN PLASMA IN HEMOPHILIA. , 1938, The Journal of clinical investigation.

[35]  F. H. Taylor,et al.  THE COAGULATION DEFECT IN HEMOPHILIA. THE EFFECT IN HEMOPHILIA OF INTRAMUSCULAR ADMINISTRATION. OF A GLOBULIN SUBSTANCE DERIVED FROM NORMAL HUMAN PLASMA. , 1937, The Journal of clinical investigation.

[36]  A. Patek,et al.  HEMOPHILIA. II. SOME PROPERTIES OF A SUBSTANCE OBTAINED FROM NORMAL HUMAN PLASMA EFFECTIVE IN ACCELERATING THE COAGULATION OF HEMOPHILIC BLOOD. , 1937, The Journal of clinical investigation.

[37]  T. Addis.  The pathogenesis of hereditary hæmophilia , 1911 .